The effectiveness of neuro-engineering treatment using HAL for intractable neurological diseases

The effectiveness of neuro-engineering treatment using HAL for intractable neurological diseases - The effectiveness of HAL for intractable neurological diseases

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000031808

Enrollment

Registered

2018-03-22

Start date

2018-03-19

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

intractable neurological diseases

Interventions

equip HAL for 3 days

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: intractable neurological diseases

Exclusion criteria

Exclusion criteria: active infectious disease systemic breakdown patient who cannot equip HAL

Design outcomes

Primary

Measure	Time frame
Simple test for evaluating hand function	—

Secondary

Measure	Time frame
Examination of muscle tonus	—

Countries

Japan

Contacts

Public ContactMASAHIKO TANIGUCHI

St. Mary Hospital Division of Transplant Surgery

m-tani@st-mary-med.or.jp0942-35-3322

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026